These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8998703)

  • 21. Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators.
    Tanaka M; Gunawan F; Terry RD; Inagaki K; Caffarelli AD; Hoyt G; Tsao PS; Mochly-Rosen D; Robbins RC
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1160-7. PubMed ID: 15867794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary calcification in heart transplants.
    Colhoun HM
    Eur Heart J; 1999 Oct; 20(20):1515. PubMed ID: 10493851
    [No Abstract]   [Full Text] [Related]  

  • 23. Thickening of arterial intima in rat cardiac allografts. A light and electron microscopic study.
    Laden AM; Sinclair RA
    Am J Pathol; 1971 Apr; 63(1):69-84. PubMed ID: 4927043
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac hyperacute rejection: a new look or a skewed look at an old problem?
    Rose AG; Cooper DK
    J Heart Lung Transplant; 2001 Jan; 20(1):103-5. PubMed ID: 11280301
    [No Abstract]   [Full Text] [Related]  

  • 25. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing complications in heart transplant recipients. Improved techniques and medications increase survival rates.
    Kobashigawa JA; Stevenson LW
    J Crit Illn; 1993 Jun; 8(6):678-89. PubMed ID: 10148766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Status of the endothelium-derived hyperpolarizing factor pathway in coronary arteries after heterotopic heart transplantation.
    Perrault LP; Aubin MC; Malo O; Thollon C; Villeneuve N; Vilaine JP; Vanhoutte PM
    J Heart Lung Transplant; 2007 Jan; 26(1):48-55. PubMed ID: 17234517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiac retransplantation in childhood. Questions and answers].
    Iserin F; Le Bidois J; Tamisier D; Sidi D
    Arch Mal Coeur Vaiss; 2003 May; 96(5):560-3. PubMed ID: 12838853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac graft vascular disease. Nonselective involvement of large and small vessels.
    Russell ME; Fujita M; Masek MA; Rowan RA; Billingham ME
    Transplantation; 1993 Dec; 56(6):1599-601. PubMed ID: 8279051
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of graft coronary arteriosclerosis after heart transplantation.
    Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A
    Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiographic, pathologic, and clinical relationships in coronary artery disease in cardiac allografts.
    Haddad M; Pflugfelder PW; Guiraudon C; Novick RJ; McKenzie FN; Menkis A; Kostuk WJ
    J Heart Lung Transplant; 2005 Sep; 24(9):1218-25. PubMed ID: 16143236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplant vasculopathy is associated with increased AlloMap gene expression score.
    Yamani MH; Taylor DO; Rodriguez ER; Cook DJ; Zhou L; Smedira N; Starling RC
    J Heart Lung Transplant; 2007 Apr; 26(4):403-6. PubMed ID: 17403484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human cytomegalovirus immediate-early protein IE2-86, but not IE1-72, causes graft coronary arteriopathy in the transplanted rat heart.
    Suzuki K; Murtuza B; Suzuki N; Khan M; Kaneda Y; Yacoub MH
    Circulation; 2002 Sep; 106(12 Suppl 1):I158-62. PubMed ID: 12354726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Coronary disease in patients undergoing heart transplantation: are there predisposing factors?].
    Bronze L; Rebocho MJ; Aguiar C; Palos JL; Silva JA; Seabra-Gomes R; Queiroz e Melo J
    Rev Port Cardiol; 1998 Jan; 17(1):53-6. PubMed ID: 9558955
    [No Abstract]   [Full Text] [Related]  

  • 37. [Accelerated coronary angiopathy in patients after cardiac transplantation].
    Parnicka-Konduracka E; Piwowarska W
    Kardiol Pol; 1993 Jul; 39(7):41-4. PubMed ID: 8411842
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
    Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
    J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptom complex is associated with transplant coronary artery disease and sudden death/resuscitated sudden death in pediatric heart transplant recipients.
    Price JF; Towbin JA; Dreyer WJ; Radovancevic B; Rosenblatt HM; Clunie SK; Denfield SW
    J Heart Lung Transplant; 2005 Nov; 24(11):1798-803. PubMed ID: 16297785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.